
#LHON: Leber Hereditary Optic Neuropathy - rare #mitochondrial disorder causing #blindness.. share info on living with LHON, research & news.
United Kingdom
Joined February 2015
- Tweets6.4K
- Following499
- Followers365
- Likes795
Bilateral visual acuity gains reported in phase 3 trial of LHON gene therapy treatment healio.com/ophthalmology/ret…
Bilateral visual acuity gains reported in phase 3 trial of LHON gene therapy treatment healio.com/ophthalmology/ret…
New data on Stealth’s Alexion-partnered asset thepharmaletter.com/article/…
Failure of mitochondrial quality control causes heart disease medicalxpress.com/news/2019-…
Clinical Trial Suggests Pomegranate Molecule Has Anti-Aging Benefits | Worldhealth.net Anti-Aging News worldhealth.net/news/clinica…
LHONUK retweeted
A new panel made up of disabled young people is being organised by @DisRightsUK
Sounds like a really exciting opportunity for anyone interested under the age of 25!
Sign up below 👇
bit.ly/2AUHQIL
LHONUK retweeted
We are excited to be at #AANEMinAustin to share two posters on our ongoing clinical trial in primary mitochondrial myopathy (PMM). Read the full abstracts for our posters (109 & 118) here: bit.ly/2nCjAYR
UK Rare diseases engagement exercise - Full survey dhsc-mail.co.uk/form/Sx1iaZD…
Study: Rett Cells Have Energy Production Defects, More Oxidative Stress rettsyndromenews.com/2019/10…
Cells’ mitochondria work much like Tesla battery packs, study finds | UCLA newsroom.ucla.edu/releases/c…
Mitochondria work more like a Tesla car battery than a household Duracell - UPI.com upi.com/Science_News/2019/10…
LHONUK retweeted
With scientific evidence supporting mechanism for bilateral visual improvement with #genetherapy GS010 for #LHON #raredisease, @GensightBio plan to file for approval in Europe in Q3 2020 mdmag.com/conference-coverag… via @mdmagazine
Gene Therapy GS010 Shows Intriguing Findings for LHON | MD Magazine mdmag.com/conference-coverag…
Gene Therapy GS010 Shows Intriguing Findings for LHON | MD Magazine mdmag.com/conference-coverag…
Stealth BioTherapeutics Does The Deal With Alexion, And Other Headlines: The Good, Bad And Ugly Of Biopharma | Seeking Alpha seekingalpha.com/article/429…
Alexion teams up with Stealth Bio to advance elamipretide | Seeking Alpha seekingalpha.com/news/350495…
Public Engagement Day – Retina Conference Dublin Iteland retina.ie/public-engagement-…
Here's Why Stealth BioTherapeutics Rocketed Higher Today fool.com/investing/2019/10/1…
Alexion bags option on Stealth's phase 3 rare disease drug | FierceBiotech fiercebiotech.com/biotech/al…



